Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (681-690 of 1,398) with videos related to

Pageof 140
Sort By:
Plos Genetics|April 6, 2012
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsMyLinh T Duong, Said Akli, Caimiao Wei, et al.
Cancer Cell|February 21, 2012
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsTaru Muranen, Laura M Selfors, Devin T Worster, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Oncogene|March 26, 2025
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Huiling Lai, Guannan Li, et al.
The New Phytologist|April 4, 2025
Investigating the accuracy of tropical woody stem CO<sub>2</sub> efflux estimates: scaling methods, and vertical and diel variationMaria B Mills, Alexander Shenkin, Phil Wilkes, et al.
Cancer Research|January 20, 2007
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cellsYoko Tabe, Linhua Jin, Yuko Tsutsumi-Ishii, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Nature Communications|September 24, 2017
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancerShreya Mitra, Jeffrey E Montgomery, Matthew J Kolar, et al.
Biomarker Research|August 19, 2025
The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancersQiuyang Xu, Yuanjia Wen, Taiyuan Huang, et al.
International Journal of Cancer|October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxinF J Xu, C M Boyer, D S Bae, et al.
Pageof 140

Showing results (681-690 of 1,398) with videos related to

Sort By:
Pageof 140
Plos Genetics|April 6, 2012
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsMyLinh T Duong, Said Akli, Caimiao Wei, et al.
Cancer Cell|February 21, 2012
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cellsTaru Muranen, Laura M Selfors, Devin T Worster, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: genome copy number abnormalities in ovarian cancerJoe W Gray, Seiji Suzuki, Wen-Lin Kuo, et al.
Oncogene|March 26, 2025
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Huiling Lai, Guannan Li, et al.
The New Phytologist|April 4, 2025
Investigating the accuracy of tropical woody stem CO<sub>2</sub> efflux estimates: scaling methods, and vertical and diel variationMaria B Mills, Alexander Shenkin, Phil Wilkes, et al.
Cancer Research|January 20, 2007
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cellsYoko Tabe, Linhua Jin, Yuko Tsutsumi-Ishii, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
Nature Communications|September 24, 2017
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancerShreya Mitra, Jeffrey E Montgomery, Matthew J Kolar, et al.
Biomarker Research|August 19, 2025
The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancersQiuyang Xu, Yuanjia Wen, Taiyuan Huang, et al.
International Journal of Cancer|October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxinF J Xu, C M Boyer, D S Bae, et al.
Pageof 140